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ABSTRACT
Background: Carbonic anhydrases (CAs) are ubiquitous, essential enzymes which
catalyze the conversion of carbon dioxide and water to bicarbonate and H+ ions.
Vertebrate genomes generally contain gene loci for 15–21 different CA isoforms,
three of which are enzymatically inactive. CAVI is the only secretory protein of the
enzymatically active isoforms. We discovered that non-mammalian CAVI contains
a C-terminal pentraxin (PTX) domain, a novel combination for both CAs and PTXs.
Methods: We isolated and sequenced zebrafish (Danio rerio) CAVI cDNA,
complete with the sequence coding for the PTX domain, and produced the
recombinant CAVI–PTX protein. Enzymatic activity and kinetic parameters were
measured with a stopped-flow instrument. Mass spectrometry, analytical gel
filtration and dynamic light scattering were used for biophysical characterization.
Sequence analyses and Bayesian phylogenetics were used in generating hypotheses of
protein structure and CAVI gene evolution. A CAVI–PTX antiserum was produced,
and the expression of CAVI protein was studied by immunohistochemistry.
A knock-down zebrafish model was constructed, and larvae were observed up to
five days post-fertilization (dpf). The expression of ca6 mRNA was quantitated by
qRT-PCR in different developmental times in morphant and wild-type larvae and in
different adult fish tissues. Finally, the swimming behavior of the morphant fish
was compared to that of wild-type fish.
Results: The recombinant enzyme has a very high carbonate dehydratase activity.
Sequencing confirms a 530-residue protein identical to one of the predicted proteins
in the Ensembl database (ensembl.org). The protein is pentameric in solution, as
studied by gel filtration and light scattering, presumably joined by the PTX domains.
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Mass spectrometry confirms the predicted signal peptide cleavage and disulfides,
and N-glycosylation in two of the four observed glycosylation motifs. Molecular
modeling of the pentamer is consistent with the modifications observed in mass
spectrometry. Phylogenetics and sequence analyses provide a consistent hypothesis
of the evolutionary history of domains associated with CAVI in mammals and non-
mammals. Briefly, the evidence suggests that ancestral CAVI was a transmembrane
protein, the exon coding for the cytoplasmic domain was replaced by one coding for
PTX domain, and finally, in the therian lineage, the PTX-coding exon was lost.
We knocked down CAVI expression in zebrafish embryos with antisense
morpholino oligonucleotides, resulting in phenotype features of decreased buoyancy
and swim bladder deflation in 4 dpf larvae.
Discussion: These findings provide novel insights into the evolution, structure, and
function of this unique CA form.
Subjects Biochemistry, Bioinformatics, Evolutionary Studies
Keywords Phylogeny, Protein modeling, Pentraxin, Zebrafish, Carbonic anhydrase VI, Carbonic
anhydrase, Mass spectrometry, Innate immunity, Knockdown
INTRODUCTION
Carbonic anhydrase VI (CAVI) is the only secretory CA enzyme in mammals. In its very
first reporting, Henkin et al. (1975) described a novel protein, gustin, from human saliva,
which was later shown to be CAVI (Thatcher et al., 1998). This protein was first described
as a CA enzyme by Fernley, Wright & Coghlan (1979), who identified a novel high
molecular weight (MW) form of CA in the sheep parotid gland and saliva. The first
immunohistochemical studies on human CAVI indicated that it is highly expressed in
the serous acinar cells of the parotid and submandibular glands (Parkkila et al., 1990). It is
one of the major protein constituents of human saliva (Parkkila et al., 1993), and also
found in human and rat milk (Karhumaa et al., 2001).
The physiological role of CAVI has remained unclear, even though it was discovered
three decades ago. Henkin’s group linked gustin (CAVI) to the regulation of taste function
(Shatzman & Henkin, 1981). Expression of CAVI in the von Ebner’s glands implicate
CAVI in the paracrine modulation of taste function and TRC apoptosis (Leinonen et al.,
2001). Various studies have later shown a link between bitter taste perception and CAVI
(Melis et al., 2013; Patrikainen et al., 2014). Two studies have shown a link between CAVI
and immunological function in mouse and human. First, Car6-/- mice have a greater
number of lymphoid follicles in the small intestinal Peyer’s patches, suggesting an
immunological phenotype (Pan et al., 2011). Second, the analysis of gene expression in the
trachea and lung of Car6-/- mice showed alterations in biological processes such as
antigen transfer to mucosal-associated lymphoid tissue (Patrikainen et al., 2016).
Innate immune systems, based on pattern recognition, exist in some form in all
metazoan organisms (Medzhitov, 2007). The pattern-recognition molecules (PRMs)
recognize conserved structures on the surface of pathogens and activate the innate
immune response. Pentraxins (PTXs) are a superfamily of fluid phase PRMs conserved in
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evolution and characterized by a cyclic multimeric structure with a regulatory role in
inflammation (Bottazzi et al., 2016). They contain a characteristic ∼200-residue-long
domain at their C-terminus. Based on their primary subunit structures PTXs are divided
into short PTXs and long PTXs. Short PTXs are classically represented by C-reactive
protein (a.k.a. CRP, pentraxin-1, PTX-1) and serum amyloid P (a.k.a. APCS, SAP,
pentraxin-2, PTX-2), whereas long PTXs comprise pentraxin-3 (PTX3), neuronal PTXs,
and others (Garlanda et al., 2005).
We noted the presence of an additional PTX domain in some non-mammalian CA6
gene predictions in 2007, but did not follow up this observation at that time. More
recently, with more non-mammalian genomes available, we realized that the PTX domain
is present in non-mammalian CAVI too consistently to be an annotation artifact, which
inspired this study. We used zebrafish (Danio rerio) as a vertebrate model organism for
functional and structural characterization of the PTX-associated CAVI.
MATERIALS AND METHODS
Sequence conservation
In order to compare conservation in the CA and PTX domains of CAVI–PTX proteins,
non-mammalian CAVI sequences were retrieved from NCBI (NCBI Resource
Coordinators, 2016) nr protein database as of December 5, 2015, using BLASTP (https://
blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) (Altschul et al., 1990), with human
CAVI (ENSP00000366662 from Ensembl (Flicek et al., 2012) as query sequence,
taxonomically filtered for non-mammalian vertebrates. Full-length or nearly full-length
CAVI–PTX sequences were seen at extremely low e values, not higher than 2  10-80,
indicating very high similarity; CAVI sequence fragments were seen at e values from 10-79
to 10-71; and the remaining matches, at e values of 10-68 and higher, were annotated as
other CA isoforms and did not contain a PTX domain. Sequences with an e value of
2  10-80 or lower were taken for further quality control. We discarded sequences shorter
than 485 residues and any with non-specific “X” characters. Furthermore, we rejected
sequences with unaligned, unique insertions of at least 20 residues at exon boundaries,
which we assume to be introns mispredicted as coding sequence. Likewise, sequences
containing gaps in the alignment between exon boundaries were interpreted to miss data
for internal exons and were discarded. Thus, all sequences which were incomplete in the
CA domain were discarded, but sequences devoid of the signal peptide region were still
kept. The final sequence set contained 78 sequences from 75 species, (sequence accession
numbers shown in Fig. S1 and in Data S1). After inspection of the multiple sequence
alignment, four sequences were edited for a more plausible initiation site (Table 1)
deemed to be at the conserved M at the start of the signal peptide region. All sequences
had complete PTX domains. Sequences were aligned with Clustal Omega (Sievers et al.,
2011). In order to calculate conserved positions in each domain, the CA domain was
defined to correspond to residues 24–280 in zebrafish CAVI (UniProt annotation in
E9QB97_DANRE), and the PTX domain was defined as residues 317–518 (InterProScan
at http://www.ebi.ac.uk/interpro/sequence-search (Jones et al., 2014), match to profile
SM00159, PTX).
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Phylogenetic analyses
For the tree in Fig. 1, cDNA sequences and their protein translations were collected from the
Ensembl database (release 67) for CAs 6, 9, 12, and 14, from selected species. Protein
sequences were aligned with Clustal Omega. Codon aligned cDNA sequences were
produced in the PAL2NAL web server v. 14 (http://www.bork.embl.de/pal2nal/)
(Suyama, Torrents & Bork, 2006) using the protein alignment as a guide (protein alignment:
Data S2; final codon alignment: Data S3). For the tree in Fig. S2, a second alignment
was similarly made using catalytic domains of CAVI sequences only (protein alignment:
Data S4; final codon alignment: Data S5). For the tree in Fig. 2, we made a third alignment
of CAVI-associated PTX domains from selected species and human PTXs (codon aligned
sequences: Data S6). The resulting codon (DNA) alignments and the program MrBayes
v 3.2 (Ronquist et al., 2012) were used to estimate the phylogeny of the sequences by Bayesian
inference. Bayesian estimation was run for at least 10,000 generations, with flat a priori
distribution of base frequencies, substitution rates, proportion of invariable sites, and
gamma shape parameter. The 50% majority rule consensus trees were saved and visualized
using the APE R package (Paradis, Claude & Strimmer, 2004).
Run lengths, relevant parameters at the end of run, and rooting of the trees were as
follows. For the first tree, the average standard deviation of split frequencies after 10,000
generations was 5.2  10-2 when the analysis was stopped. The arithmetic mean of the
estimated marginal likelihoods for runs sampled was -17175.07. Drosophila melanogaster
CAH1 sequence was used as an outgroup to root the tree. For the second tree, the average
standard deviation of split frequencies after 20,000 generations was 1.2  10-1 when
the analysis was stopped. The arithmetic mean of the estimated marginal likelihoods
for runs sampled was -10596.5. Fish sequences were used as an outgroup to root the
consensus tree. Branching points with lower than 50% consensus in the mammal branch
are collapsed. Finally, for the third tree, the average standard deviation of split frequencies
after 10,000 generations was 8.1  10-2 when the analysis was stopped. The arithmetic
mean of the estimated marginal likelihoods for runs sampled was -10319.1.
BlastN search in platypus genome
In order to see if the orphan fragment Contig22468 of platypus genome (which
contains the exon coding for a “CAVI-type” PTX domain) would have been somehow
Table 1 Suggested corrections for predicted translation start sites.
RefSeq ID Name Organism Number of
N-terminal
residues removed
XP_010721064.1 PREDICTED: carbonic anhydrase 6 Meleagris gallopavo 110
XP_005057921.1 PREDICTED: carbonic anhydrase 6 Ficedula albicollis 17
XP_002187446.1 PREDICTED: carbonic anhydrase 6 Taeniopygia guttata 6
XP_005143337.1 PREDICTED: carbonic anhydrase 6 Melopsittacus undulatus 31
Note:
The following database entries have N-terminal extensions which we assume mispredicted. We have shortened these
sequences to start at a conserved initiating Met residues for use in this study.
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missed in the genome assembly, we performed a BlastN search in Ensembl (http://www.
ensembl.org/Homo_sapiens/Tools/Blast?db=core). BlastN was run against the platypus
genome with the full 11,311 nt sequence of supercontig:OANA5:Contig22468 as query
sequence.
Exon length comparisons
Exon data was retrieved from Ensembl. Lengths of the exons that follow those coding for
the CA domain were noted for Ensembl transcripts for human CA6 (ENST00000377443),
CA9 (ENST00000378357), CA12 (ENST00000178638 and ENST00000344366), and
CA14 (ENST00000369111), and zebrafish ca6 (ENSDART00000132733). Similarly,
Homo sapiens CA XIV
Mus musculus CA XIV
Monodelphis domestica CA XIV
Meleagris gallopavo CA XIV
Xenopus tropicalis CA XIV
Latimeria chalumnae CA XIV
Danio rerio CA XIV
Homo sapiens CA XII
Mus musculus CA XII
Monodelphis domestica CA XII
Meleagris gallopavo CA XII
Latimeria chalumnae CA XII
Danio rerio CA XII
Xenopus tropicalis CA XII
Homo sapiens CA IX
Mus musculus CA IX
Monodelphis domestica CA IX
Chrysemys picta bellii CA IX
Gallus gallus CA IX
Latimeria chalumnae CA IX
Danio rerio CA IX
Gallus gallus CA VI
Meleagris gallopavo CA VI
Xenopus tropicalis CA VI
Danio rerio CA VI
Mus musculus CA VI
Homo sapiens CA VI











































Figure 1 Bayesian phylogenetic tree of CA VI, CA IX, CA XII, and CA XIV. Analysis of protein
alignment guided DNA alignments as detailed in “Materials and Methods.” Sidebars indicate the groups
of isoforms. The CAVI subtree with more species is shown in Fig. S2.
Full-size DOI: 10.7717/peerj.4128/fig-1
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lengths of the exons preceding the PTX domain exon were noted for Ensembl transcripts
of human CRP (ENST00000255030), APCS (SAP, ENST00000255040).
Amphipathic helix prediction
A study of the region between the CA and PTX domains in the alignment of CAVI protein
sequences showed little conservation except for five sites with hydrophobic residues
spaced three or four residues apart, with mostly polar residues between them, suggestive
of an amphipathic alpha helix. The subsequences from 287 to 303 and from 293 to 309
for human and zebrafish CAVI, respectively, were visualized as helical wheel diagrams, or
end projections of a hypothetical alpha helix of 17 residues, using the PepWheel program
of the EMBOSS suite (http://www.bioinformatics.nl/cgi-bin/emboss/help/pepwheel)


























































Figure 2 Bayesian phylogenetic tree of pentraxin domains. Analysis of protein alignment guided DNA
alignments as detailed in “Materials and Methods.” Sidebars indicate PTX domains extracted from non-
mammalian CAVI sequences (bottom) and groups of human pentraxins.
Full-size DOI: 10.7717/peerj.4128/fig-2
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Construction of recombinant baculoviruses
The 1,593 bp zebrafish ca6 sequence encoding the full-length, PTX-containing
CAVI polypeptide (CAVI–PTX) was amplified by PCR using the forward
primer 5′-ATGGAGCAGCTGACTCTAGTC-3′ and reverse primer
5′-TTTCTCTGTTTCTCTATTATTATTAT-3′. PCR conditions consisted of an initial
denaturation step at 98 C for 30 s followed by 35 cycles at 98 C for 10 s (denaturation),
55 C for 30 s (annealing), and 72 C for 25 s (elongation). The final extension step was
carried out at 72 C for 5 min. The expression construct was optimized for protein
production in Spodoptera frugiperda insect cells (Sf9) by inserting into second round PCR
primers restriction sites for BamHI and SalI plus sequences coding for C-terminal
histidine tag for protein purification and a thrombin cleavage site for tag removal. The
second round of PCR was carried out using the protocol described above, except that
the temperature for annealing was 62 C, and final extension step was carried out at 74 C
for 7 min. The baculoviral genomes encoding CAVI recombinant proteins were generated
according to the Bac-to-Bac Baculovirus Expression System instructions (Invitrogen,
Camarillo, CA, USA). The recombinant protein insert was sequenced using ABI
PRISM BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems, Inc.,
Foster City, CA, USA.) and pFASTBac primers (forward: 5′-AATGATAACCATCTGGCA-3′
and reverse: 5′-GGTATGGCTGATTATGAT-3′) in order to obtain the full-length insert
sequence. The PCR conditions consisted of 35 cycles at 96 C for 10 s (denaturation), 50 C
for 5 s (annealing), and 55 C for 4 min (elongation) with final extension at 37 C for 5 min.
Production and purification of recombinant CA VI–PTX
The Sf9 insect cells (Invitrogen) were maintained in HyQ SFX-Insect serum-free cell
culture medium (HyClone, Logan, UT, USA). The cells were centrifuged (2,000g, at
20 C, for 5 min) 72 h after infection, and the medium was collected. Purification was
performed with the Probond Purification System (Invitrogen) under native binding
conditions with wash and elution buffers made according to the manufacturer’s
instructions. Purity of the protein was checked and the MW of the recombinant protein
was determined by running a 10% SDS-PAGE (sodium dodecyl sulfate-polyacrylamide
gel electrophoresis) under reducing conditions. The size of the protein was determined
using Precision Plus ProteinTM Standards Dual Color (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA) and MWmarker and bands were visualized using the Colloidal
Blue Staining KitTM (Invitrogen).
CA activity/inhibition assay
An Applied Photophysics stopped-flow instrument was used for assaying the CA catalyzed
CO2 hydration activity (Khalifah, 1971). The method was exactly as described previously
(Berrino et al., 2017) except that the inhibitor dilutions were done up to 0.5 nM.
Light scattering experiments
Molecular weight determination of zebrafish CAVI–PTX was performed using a Malvern
Zetasizer mV instrument (Malvern Instruments Ltd., Worcestershire, UK) running
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static light scattering (SLS) and dynamic light scattering (DLS) methods. Analysis
was performed using a liquid chromatography instrument (CBM-20A, Shimadzu
Corporation, Kyoto, Japan) equipped with autosampler (SIL-20A), UV–VIS (SPD-20A)
and fluorescence detector (RF-20Axs). Data were processed using Lab Solution Version 5.51
(Shimadzu Corporation) and OmniSec 4.7 (Malvern Instruments Ltd., Worcestershire,
UK) softwares. A sample of the protein (50 mg) was injected on a Superdex
200 5/150 column (GE Healthcare, Uppsala, Sweden) equilibrated with 50 mMNaH3PO4,
500 mM NaCl pH 8 buffer. Runs were performed with flow rate of 0.1 ml/min at 20 C
using a thermostated cabin. The MWof the zebrafish CAVI–PTX was determined either
by using a standard curve based on MW standard proteins (SEC analysis; CA 29 kDa,
alcohol dehydrogenase 150 kDa, b-amylase 200 kDa, BSA 66 kDa, Sigma-Aldrich, Inc.,
St. Louis, MO, USA) or by calibrating the light scattering detector using the monomeric
peak of BSA and light-scattering intensity (SLS).
Sample preparation for mass spectrometry
Prior to the mass spectrometric measurements, the CA VI–PTX sample was buffer-
exchanged to 10 mM ammonium acetate (pH 7.5) buffer using Sephadex G-25 M
(PD-10) desalting columns (GE Healthcare, Gillingham, UK). Ten 1 ml fractions were
collected, and the fractions containing protein were concentrated using Amicon Ultra
(5 kDa cut-off) centrifugal filter devices (Merck Millipore, Darmstadt, Germany). Finally,
protein concentrations were determined by UV-absorbance at 280 nm, using a sequence-
derived extinction coefficient 99,155 M-1 cm-1, calculated by ProtParam at http://web.
expasy.org/protparam/ (Gasteiger et al., 2003). Intact protein mass analysis was performed
by diluting the sample to the desired protein concentration with acetonitrile (MeCN),
containing 1% of acetic acid (HOAc). Alternatively, CAVI–PTX was digested with trypsin.
Briefly, an aliquot of the CAVI–PTX sample was mixed with a sequencing grade modified
trypsin (Promega, Madison, WI, USA) (3 mg/ml in water) to obtain a 1:20 (w/w)
protease-to-protein ratio. The digest sample was incubated at 37 C for 1 h, and
subsequently diluted to approximately 10 mM with MeCN containing 1% HOAc.
Mass measurements and data analysis
All experiments were performed on a 12-T Bruker Solarix-XR FT-ICR mass spectrometer
(Bruker Daltonik GmbH, Bremen, Germany), equipped with an Apollo-II electrospray
ionization (ESI) source and a dynamically harmonized ParaCell ICR-cell. All protein/
peptide samples were directly infused into the ESI source at a flow rate of 1.5 mL/min. The
ESI-generated ions were externally accumulated in the hexapole collision cell for 1 s, and
transferred to the ICR cell for trapping, excitation and detection. For each mass spectrum,
a total of 300 time-domain transients (1 MWord each) were co-added, and zero-filled
once to obtain final 2 MWord broadband data. For collision-induced dissociation
tandem mass spectrometry (CID-MS/MS) experiments, the precursor ions of interest
were mass-selected in a quadrupole and fragmented in the collision cell by increasing the
collision voltage to the appropriate value. The mass spectra were externally calibrated with
ESI-L Low concentration tuning mix (Part no G1969-85000; Agilent Technologies,
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Santa Clara, CA, USA). The instrument was operated and the data were acquired by using
Bruker ftmsControl 2.0 software. The mass spectra were subsequently transferred to
Bruker DataAnalysis 4.4 software for further processing. Spectral de-isotoping and
charge-state deconvolution (to obtain monoisotopic peptide masses) was accomplished
with a Bruker SNAP2 peak-picking module. The obtained mass lists were then uploaded
to GPMAW 10.0 software (Lighthouse Data, Odense, Denmark) for tryptic peptide
identification. Only specific tryptic peptides were searched with a maximummass error of
5 ppm. The glycosylation sites in CAVI–PTX were identified by incorporating typical
high-mannose/complex glycans with a various number of residues into the four putative
N-glycosylation sites and searched against the obtained mass lists.
Homology modeling of zebrafish CA VI
We built a 3D model of zebrafish CAVI starting from PDB 3FE4, human CAVI
(Pilka et al., 2012); and 4AVS, human SAP component (Kolstoe et al., 2014), as templates
for the CA domain and PTX domain, respectively. The CA template includes residues
32–280 of human CAVI, missing 14 residues in the N-terminus of the mature protein, and
28 residues in the C-terminus. Briefly, the predicted amphipathic helix (APH) region of
human CAVI (287–303) and four additional residues (283–286) were modeled as an
alpha helix, and the helix was subsequently docked to the C-terminal face of 3FE4. This
extended model of human CAVI was used as a template in homology modeling the
CA domain plus APH of zebrafish CAVI. The model of the PTX domain of zebrafish
CAVI was docked to the model of CA+APH domains. Finally, a pentameric model of
CA VI–PTX was created by superimposing five copies of the monomer model over each
monomer in the pentameric SAP structure (PDB 4AVS).
The C-terminal alpha helix was generated automatically ab initio for the region
predicted to form an APH when the full sequence of human CAVI was given as a
modeling target to I-TASSER 4.0 (Roy, Kucukural & Zhang, 2010). The helix was separated
from the model and subsequently docked to 3FE4, using the HADDOCK 2.1 server
(http://haddock.science.uu.nl/) (de Vries et al., 2007). A list of potential interface residues
in 3FE4 were predicted through CPORT (http://milou.science.uu.nl/services/CPORT/)
(de Vries & Bonvin, 2011), and only those lying on the C-terminal face of 3FE4 were set as
interacting residues in docking. For the APH, the residues located on the hydrophobic
side were chosen as interacting residues. The resulting model from this docking step was
used as a template to model the full CA domain of zebrafish CAVI at the MODELLER
server (Webb & Sali, 2016) using UCSF Chimera v. 1.10 (Pettersen et al., 2004) as the
interface program. The PTX domain of zebrafish CAVI (residues 317–530) was also
modeled by MODELLER, with 4AVS as template. The two partial models of zebrafish
CAVI were joined by docking with HADDOCK, again predicting interacting residues
with CPORT. Most of the predicted interacting residues were located near the C-terminus
of the CA domain and near the N-terminus of the PTX domain, and the residues in these
regions were chosen as active residues in docking. The structural superimpositions of the
PTX domains of the CAVI–PTX monomer on the SAP pentamer (4AVS) were carried out
with the MatchMaker tool in UCSF Chimera to generate the final pentamer model.
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Zebrafish maintenance and ethical permissions
Wild-type zebrafish of the AB strain were maintained at 28.5 C under standard
conditions (Westerfield, 2007). We express the embryonic ages in hours post-fertilization
(hpf) and days post-fertilization (dpf). Embryos/larvae were collected from the breeder
tanks with a sieve and rinsed with embryonic medium (Sarsted, Nu¨mbrecht, Germany)
into Petri dishes. Embryos/larvae were kept in Petri dishes in embryonic medium
supplemented with 1-phenyl-2-thiourea (Sigma-Aldrich) at 28.5 C until they were used
in experiments. The maximum number of larvae on a 9 cm diameter Petri dish was 50.
Embryonic medium contained 5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM
MgSO4 and 10–5% methylene blue (Sigma-Aldrich). Zebrafish housing and care in the
Zebrafish facility of the University of Tampere have been approved by the National Animal
Experiment Board of Finland, administered through the Provincial Government of
Western Finland, Province Social and Health Department Tampere Regional Service Unit
(permit # LSLH-2007-7254/Ym-23). Using five-day old zebrafish as a model organism
requires no specific ethical permission, neither does studying tissues collected from
euthanized adult fish.
Morpholino injections of zebrafish embryos
Knockdown of ca6 was carried out using two different antisense morpholino
oligonucleotides (MOs) (GeneTools LLC, Philomath, OR, USA): one translation-blocking
(MO1 5′-CTGCCTGTGCTCTGAACTGTTTCTC-3′) and the other splicing-blocking,
to target intron–exon boundary before exon 9 (MO2 5′-GCTTGCCTTGAGAAGGAAA
GATCAT). The random control (RC) MOs (5′-CCTCTTACCTCAGTTACAATTTATA-3′)
were used as control MOs. The supplied MOs were re-suspended in sterile water at 1 mM
stock concentration. Immediately prior to injection, ca6-MOs were diluted to the
intended concentration of 125 mM. In order to monitor injection efficiency, 0.2% dextran
rhodamine B and 0.1% phenol red (final concentrations; Sigma, Poole, UK) were included
in the solution, and the final KCl concentration was adjusted to 1 M. About 1 nl of
antisense MO solution was injected into the yolk of approximately 500 one- to two-cell
stage embryos, without randomization. The MO-injected embryos were screened for the
presence of fluorescence after 24 h to select the true ca6 morphants using Lumar V1.1
fluorescence stereomicroscope (Carl Zeiss MicroImaging GmbH, Go¨ttingen, Germany)
and AxioVision software version 4.9. The non-fluorescent embryos were eliminated.
Microscopy and live image analysis of zebrafish phenotypes
Gross phenotypic appearance was analyzed by light-field microscopy. For each
experiment, typically 10–20 ca6-MO-injected larvae were screened with a similar number
of matched controls. Larvae were first euthanized using 0.05% tricaine (Sigma-Aldrich)
in embryo medium and embedded in 17% high MWmethyl cellulose in 15  30 mm
transparent polypropylene Petri dish for taking images of the developing embryos/larvae
from 1 to 5 dpf using Zeiss Stereo Microscope (Carl Zeiss MicroImaging GmbH,
Go¨ttingen, Germany) with NeoLumar S 1.5Objective (Carl Zeiss MicroImaging GmbH,
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Go¨ttingen, Germany). The images were analyzed with AxioVision software version 4.9.
and scale bars were inserted. Images were cropped and assembled into composite images.
Isolation of total RNA and synthesis of cDNA
Total RNA was isolated at different stages of development, from 0 to 168 hpf whole
embryos/larvae, and from different organs of the adult zebrafish. Total RNA was isolated
from 30 mg samples using the RNeasy Mini kit (Qiagen, Hilden, Germany) by following
the manufacturer’s instructions. The concentration and purity of total RNA were
determined using a Nanodrop UV/VIS Spectrophotometer at 260 and 280 nm. Reverse
transcriptase PCR was performed using 0.1–5 mg of total RNA to synthesize the first
strand cDNA using First Strand cDNA Synthesis kit (High-Capacity cDNA Reverse
Transcription Kits; Applied Biosystems, Foster City, CA, USA) with random primers
and M-MuLV reverse transcriptase according to the protocol recommended by the
manufacturer.
Quantitative real-time PCR
Quantitative real-time PCR (qRT-PCR) primers were designed based on the complete
cDNA sequence taken from Ensembl (ENSDART00000057097), using the program
Primer Express Software v2.0 (Applied Biosystems) (forward primer 5′-CAAACATTTAT
TTGCCAGCACTCC-3′ and reverse primer 5′-TATGTCCAATAATCTCCATCTACTCC-3′).
qRT-PCR was performed using the SYBR Green PCR Master Mix Kit in an ABI PRISM
7000 Detection SystemTM according to the manufacturer’s instructions (Applied
Biosystems). The PCR conditions consisted of an initial denaturation step at 95 C for
10 min followed by 40 cycles at 95 C for 15 s (denaturation) and 60 C for 1 min
(elongation). The data were analyzed using the ABI PRISM 7000 SDSTM software (Applied
Biosystems). Every PCR was performed in a total reaction volume of 15 ml containing 2 ml
of first strand cDNA (20 ng cDNA), 1  Power SYBR green PCR Master MixTM (Applied
Biosystems, Foster City, CA, USA), and 0.5 mM of each primer. We performed these
experiments in duplicate and with sample duplicates. The results of ca6 gene expression
were normalized using zebrafish housekeeping gene gapdh as internal control. The final
results are given as relative expression values, calculated according to the Pfaffl’s equation
(Pfaffl, 2001).
Preparation of zebrafish tissues
The adult zebrafish were euthanized by keeping them in 1% tricaine on ice for more
than 10 min followed by decapitation. Different organs were harvested under the
microscope and immediately transferred them to 1.5 ml microcentrifuge tube containing
RNAlater (Ambion, Austin, TX, USA) and were stored at -20 C until further analysis.
Simultaneously tissues for immunohistochemical analysis were harvested and
immediately fixed with 4% PFA for 24 h at 4 C. Tissues were transferred to 20% sucrose
in PBS and stored at 4 C until embedding them in Tissue-Tek O.C.T.TM Compound
(Sakura Finetek Europe B.V., Alphen aan den Rijn, The Netherlands). Embedded tissue
samples were stored at -20 C until further analysis.
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Antibody testing
Antibody against zebrafish CAVI–PTX was manufactured by Innovagen AB (Innovagen
AB, Lund, Sweden) according to their standard immunization schedule, with boosters at 14,
28, 49, and 70 days. Pre-immune serum and three samples of polyclonal antiserum were
tested using dot blotting. Bio-Dot Microfiltration Apparatus (BioRad Laboratories, Inc.,
Hercules, CA, USA) was used to attach 500 ng of produced and purified native
zebrafish CA VI–PTX protein to PROTRAN nitrocellulose (NC) transfer membrane
(Schleicher & Schuell GmbH, Dassel, Germany) according to manufacturer’s
instructions. Prior to staining, non-specific binding of the primary antibody was
prevented using diluted colostrum (1:10 in Tris-Buffered Saline with Tween 20 [TBST])
as a blocking agent for 30 min. Pre-immune serum, bleed 1 (day 41), bleed 2 (day 62),
and bleed 3 (day 83) of polyclonal rabbit anti-zebrafish CAVI-PTX (Innovagen AB,
Lund, Sweden), diluted 1:100 in TBST, were added to NC strips which were incubated at
room temperature for 1 h. Donkey anti-rabbit IgG, horseradish peroxidase linked whole
antibody (Amersham Biosciences, GE Healthcare Life Sciences, Little Chalfont, UK)
diluted 1:25,000 in TBST was used as secondary antibody. Washing steps were carried
out using TBST. Staining was carried out using ImmPACTTM DAB Peroxidase
Substrate Kit (Vector Laboratories, Inc., Burlingame, CA, USA). The testing showed that
bleed 1 and bleed 2 have a strong reactivity against zebrafish CAVI–PTX (Figs. S3B and
S3C). Antiserum of bleed 2 was used in further experiments.
Immunohistochemistry of zebrafish tissues
The Tissue-Tek O.C.T.TM Compound-embedded samples were cut into 10 mm sections
using cryotome and prior to staining, the sections were attached to the glass slide by
incubating at 37 C overnight. Staining procedure of tissue samples was carried out as
described above. Alexa Fluor goat anti-rabbit IgG 1:1,000 (Life Technologies, Carlsbad,
CA, USA) was used as a secondary antibody, and sections were mounted with Vectashield
Hard Set Mounting Medium with nuclear dye DAPI (4′,6-diamidino-2-phenylindole,
Vector Laboratories Inc., Burlingame, CA, USA). The sections were photographed using
Zeiss LSM780 Laser Scanning Confocal Microscope with Zeiss Cell Observer.Z1
microscope, Plan-Apochromat 40/1.4 (oil) objective, with pulsed diode laser 405 nm
and multiline Argon laser: 488 nm, and Quasar spectral GaAsP PMT array detector
(Carl Zeiss Microscopy GmbH, Go¨ttingen, Germany). Images were analysed with Zeiss
ZEN2Lite.
Behavioral analysis of 4 and 5 dpf ca6 knockdown zebrafish larvae
Larvae were tested for behavioral consequences due to ca6 knockdown by measuring
swimming pattern at 4 and 5 dpf. The ca6 knockdown larvae and two controls, namely
uninjected wild-type and RC MO-injected, were raised in embryo medium. Larvae
(approximately 10/flask) were placed in a 23  43 45 mm TC Flask T25 (Sarstedt AG &
Co., Nu¨mbrecht, Germany) containing 40 ml embryo medium at 3 dpf and allowed to
acclimate to the flask for 24 h at 28.5 C standard conditions. At 4 and 5 dpf their
swimming patterns were observed by a 1 min video recording, with a printed 1  1 cm
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grid behind the flask. In total, the movement patterns of 284 zebrafish were recorded
and measured: 41 of 4 dpf WT, 130 of 4 dpf KD, 32 of 5 dpf WT, and 81 of 5 dpf KD.
Sample sizes of at least 30 per group were chosen a priori because normality of
distributions could not be assumed.
Figure 3 Zebrafish wild-type and ca6 knockdownmovement analysis. Boxplots from video analysis of
1 min of swimming of zebrafish larvae. KD, knockdown;WT, wild-type. Same data used for both (A and B).
Statistics of both analyses are given in Table 3. (A) Total distances traveled. (B) Time spent in the upper half
of the tank (seconds, out of 60 s). Full-size DOI: 10.7717/peerj.4128/fig-3
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The movements of all of the larvae were analyzed using the MtrackJ plugin (Meijering,
Dzyubachyk & Smal, 2012) within the ImageJ program (Schneider, Rasband & Eliceiri,
2012). Tracking and recording of fish movements and analysis of movement data were
assigned to two separate researchers to avoid biasing the analysis. Distances traveled
(cm per 1 min, for Fig. 3A) and time spent in the upper half of the tank (seconds, out of
60 s, for Fig. 3B) were calculated for each fish, compiled by group, and presented as
boxplots using the Matplotlib (Hunter, 2007) Python library. Statistical testing of
similarity between each group, using the Kolmogorov–Smirnov two sample test, was
performed using the Stats module of the SciPy Python library (van der Walt, Colbert &
Varoquaux, 2011). The two-sample Kolmogorov–Smirnov test was chosen because it
makes no assumption about the distribution of data.
RESULTS
Non-mammalian CA VI contains an additional PTX domain
We retrieved 78 CAVI protein sequences from 75 non-mammalian species in NCBI
GenPept, all of which have the C-terminal PTX domain. The PTX domain in CAVI is less
conserved than the CA domain. The multiple sequence alignment of the 78 CAVI
sequences (Fig. S1) shows that there are 83 perfectly conserved amino acids within the
catalytic domain (within MSA columns 30–288), whereas only 19 amino acids in the PTX
domain are perfectly conserved (within MSA columns 355–566). The region between the
CA and PTX domains consists of a moderately conserved and gapless region (MSA
columns 300–320) flanked by two highly variable regions of flexible length (MSA columns
292–297 and 326–344). The presence of CA and PTX domains in non-mammalian
CAVI sequences has also been documented in the Pfam database since many years
(Finn et al., 2016), for example in http://pfam.xfam.org/protein/E9QB97_DANRE.
Figure 1 presents the phylogenetic tree of CAs VI, IX, XII, and XIV, clearly showing that
the longer, non-mammalian isoforms (with a PTX domain) are orthologs of mammalian
CAVI. The pairwise arrangement of VI/IX vs. XII/XIV is the same as in previous
phylogenetic work (Hewett-Emmett, 2000), suggesting that these four CA isozymes
descend from one common ancestor. Figure 2 shows a phylogenetic tree of all human
PTXs and selected CA-linked PTX domains, which indicates that the novel PTX domains
would be most closely related to the short PTXs, CRP and APCS or SAP.
Platypus (Ornithorhynchus anatinus) is probably an exception in the
pattern of mammals not having a PTX domain associated with CA VI
A genomic fragment not assigned to any chromosome (Contig22468 in assembly
WUGSC 5.0.1/ornAna1) contains an exon which codes for a PTX domain unlike any
that we find in other mammalian species, and most similar to CAVI-linked PTX domains
in non-mammalian species. The phylogenetic tree in Fig. 2 demonstrates that this
platypus PTX sequence is orthologous with the PTX sequences associated with CAVI in
non-mammalian species. What is more, a BLASTN search of Contig22468 against the
platypus genome showed that it partially matches a region in chromosome 5 right after
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the CA6 locus. More specifically, the first 703 bp of Contig22468 match the last 703 bases
(99.86% identity, a single mismatch) of Contig3933.5.
The adjacent location of Contig3933.5 to Contig3933.4, the fragment containing the
exons coding for the CA6 ortholog (ENSOANG00000013215), would put the exon
coding for the PTX domain in the correct location and orientation to be part of the
platypus CA6 gene if Contig22468 were placed in this position. Therefore, we tentatively
label this PTX domain as “CA-linked” and suggest that Contig22468 would be more
correctly mapped starting from Chr5:18954728 in platypus genome assembly OANA5.
With this evidence, we also suggest that CAVI in platypus contains a PTX domain, and
consequently, that the loss of PTX domain occurred after the separation of monotreme
and therian lineages in mammals.
One further phylogenetic tree was made based on CA domain sequences, showing that
phylogeny of CAVI follows the expected vertebrate phylogeny, with platypus placed
outside of marsupials and placental mammals (Fig. S2).
Exon lengths suggest that the region after the CA domain in CA VI
descends from the transmembrane helix of the ancestral form
Mammalian CAVI proteins contain an additional C-terminal region of at least
25 residues, which is dissimilar to anything in other vertebrate CA isoforms and of
unknown structure. Non-mammalian CAVI contains a sequence homologous to this
extension as a spacer region between the CA and PTX domains. In order to investigate
the most likely origin of the spacer region, we compared the exon lengths in CA6 and the
most closely related CA genes (CA9, CA12, and CA14) and short PTXs. The length of
the exon coding for the spacer between CA and PTX domains in zebrafish ca6 is 84 bp,
and the coding sequence of the homologous exon in human CA6 is 83 bp. The exons
coding for the region containing the transmembrane (TM) helices (penultimate exons) in
CA9, CA12, and CA14 are 82, 85, and 85 bp in length, respectively. Assuming a novel
juxtaposition of exons between genes coding for the ancestral TM form of CA6 and a short
PTX, the final exon of CA6 and the first exon of the PTX gene are less likely to have been
retained. Because they contain non-coding UTR sequences and lack splice donor and
acceptor sites, they would be unlikely to be spliced correctly as continuous, protein-coding
sequence. Taken together, this suggests that only the exon coding for the cytoplasmic
domain of ancestral CA VI was lost and replaced by the single exon coding for the PTX
domain. This also implies that the last exon in mammalian CA6 and the penultimate exon
of non-mammalian CA6, predicted to code for an APH (see below), and the penultimate
exons of CA9, CA12, and CA14, coding for the TM helix, are highly likely to share a
common ancestry.
The region after the CA domain is predicted to contain an APH
The pattern of hydrophobic residues repeating approximately every fourth residue is
obvious in the alignment of the region following the CA domain (final domain in
mammalian CAVI, or the segment between CA and PTX domains in non-mammalian
CAVI), as seen in Fig. 4C and in the larger alignment of Fig. S1. The helical wheel
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visualizations of Figs. 4A and 4B indicate that when folded as an alpha helix, this region of
human and zebrafish CAVI, respectively, would be an APH, with one side lined with
mainly hydrophobic residues (in blue and lilac). Furthermore, this region (292–312)
in zebrafish CAVI is also predicted to have a high potential to form a coiled-coil
structure by the COILS algorithm (Lupas, Van Dyke & Stock, 1991) in InterProScan at
http://www.ebi.ac.uk/interpro/sequence-search (Jones et al., 2014). The APH region is a
unique feature of CAVI, present in both non-mammalian and mammalian sequences.
Duplication of an adjacent glucose transporter gene is associated
with the loss of PTX from CA VI
The genes next to CA6 provide a clue for a possible cause of losing the PTX-encoding exon
in mammalian CA6. We have observed 17 non-mammalian genomes with a chromosomal
arrangement of CA6, then one glucose transporter gene (SLC2A5/SLC2A7), followed
by the gene GPR157, whereas most mammalian genomes present the gene order CA6,
SLC2A7, SLC2A5, andGPR157. The reconstructed syntenic block for therian mammals in the
region after CA6 in Genomicus (http://www.genomicus.biologie.ens.fr/genomicus-86.01)
Figure 4 Amphipathic helix analysis in CAVI. (A) Helical wheel diagram of human CAVI (287–303).
(B) Helical wheel diagram of zebrafish CA VI (293–310). Multiple sequence alignment of the spacer
region of CAVI from indicated species. (C) CA indicates the end of the catalytic CA domain; APH is the
suggested amphipathic helix, which is analyzed in (A) and (B); and PTX indicates the approximate start
of the pentraxin domain (not applicable to Homo sapiens CAVI).
Full-size DOI: 10.7717/peerj.4128/fig-4
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(Muffato et al., 2010) also shows the duplicated glucose transporter, whereas those for
ancestral tetrapods and bony fish lineages only have a single SLC2A5/SLC2A7 ortholog.
We were not able to find any single genome containing a PTX-coding exon with CA6
and both SLC2A5 and SLC2A7. Hence, the available genomic evidence suggests that
the loss of the PTX-domain-coding exon and the duplication of the adjacent glucose
transporter gene may have occurred simultaneously, close to the divergence time of the
mammalian lineage. The rearrangements during the gene duplication would also provide
a plausible mechanism for the exon loss.
Sequencing of zebrafish ca6 cDNA confirms a
530-residue product
We produced a PCR-amplified cDNA of zebrafish ca6 for recombinant protein
production. The resulting sequence had five synonymous substitutions compared to
Ensembl ENSDART00000132733 (Fig. S4) and three unresolved bases leading to one
unknown amino acid residue. Except for the unknown residue, the translation is
identical to the predicted 530-residue protein (Ensembl ENSDARP00000119189 or
UniProt E9QB97, Fig. S5). The cDNA sequence has been submitted to ENA database
(http://www.ebi.ac.uk/ena) as LT724251 and its translation to UniProt as A0A1R4AHH7.
The other predicted Ensembl transcript (ENSDART00000079007) codes for a protein
of 538 residues, in which an additional 24 bp exon creates an insertion before the
PTX domain.
Sequence alignment predicts three disulfides in zebrafish CA VI
Cysteine pairs 44/226 in (CA domain, MSA columns 51/234 in Fig. S1), 352/408, and
487/518 (PTX domain, columns 390/453 and columns 532/564, respectively in Fig. S1) are
expected to form disulfides by sequence conservation in the multiple sequence alignment.
All three disulfides are also structurally verified. The one in CA domain is seen in all
structures of extracellular CAs, e.g., human CAVI in PDB 3FE4 (Pilka et al., 2012), and the
disulfide 352/408 in the PTX domain is homologous to the one in short PTXs, e.g., human
CRP in PDB 3PVN (Guillon et al., 2014). The third disulfide, 487/518, is also supported
by proximity in our molecular model (Fig. 5A). There is one further unpaired Cys290,
in the region between the CA and PTX domains (and missing from the model), which
is also conserved in 76 of 78 non-mammalian sequences (Fig. S1).
3D model of zebrafish CA VI–PTX is compatible with predicted APH
and disulfides
We made a homology-based model of the CA and PTX domains and combined it with an
alpha helical model of the predicted APH region, using protein–protein docking to create
the nearly full model. Figure 5A shows the model, in two orientations, with the CA
domain at the top and the PTX domain at the bottom. The APH (pink) fills a non-polar
cavity on the surface of the CA domain. The precise orientation of the PTX domain is
impossible to predict with certainty, but the current model shows it leaning against the
CA domain and APH. The most highly variable regions, for which no template was
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available, were not modeled (residues 281–292 and 311–317), indicated by yellow dotted
lines (Fig. 5A). In addition, the N-terminus of the model is incomplete, missing residues
20–31, which are not visible in the template 3FE4.
The zinc-binding histidines in the active site of the CA domain are shown as yellow
sticks in Fig. 5A (zinc not shown), with the active-site cavity opening upwards. Disulfide-
forming cysteines are presented as orange stick models. The disulfide in the CA domain
and the one in the beta sheet of the PTX domain (lowest in Fig. 4A) are also present in the
templates. The information of the predicted third disulfide on the surface of the PTX
domain was not used when building the model, but the cysteines ended in close proximity
so that the disulfide could be constructed by minor refinement of the model. This
Figure 5 Molecular models of zebrafish CA VI–PTX. (A) One protomer shown in two orientations,
CA domain at the top, PTX at the bottom. Potential glycosylation site Asn residues are shown as spheres,
active-site histidines and assumed disulfide cysteines as sticks. (B) Front view of the pentamer model. In
(B–D), individual protomers are shown in different colors. Asn residues in glycosylation sites and active-
site histidines are shown in spheres, cysteines not highlighted. (C) Back view of the pentamer model.
(D) Side view of the pentamer model, seen from the top of (C), with back view downwards.
Full-size DOI: 10.7717/peerj.4128/fig-5
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disulfide would lock the C-terminus of the PTX domain on the surface of the domain. The
presumably unpaired Cys290 is part of an unmodeled region.
Based on the pentamerization tendency of mammalian PTX domains, we constructed
an additional pentameric model of zebrafish CAVI (Figs. 5B–5D) by superimposing the
PTX domains of five copies of the monomer model on the pentameric structure of SAP
(PDB 4AVS). Individual monomers are presented in different surface colors. There are no
serious steric clashes in the model, and the domain axes align to make a flat pentamer
complex (Fig. 5D), even if no pentamer constraints were applied for the monomer model.
Furthermore, adjacent monomers form an additional protein–protein interface between
the sides of their PTX and CA domains. The general shape of the modeled pentamer
is a flat, roughly planar five-pointed star, thickness 4–5 nm and an approximate diameter
15 nm. The active site of CA faces outward in the pentamer so that the zinc-binding
histidines (yellow spheres in panels B–D) are exposed in the active-site cavity, as seen
in the center of panel D.
The four potentially N-glycosylated Asn residues (in the motif Asn-X-Ser/Thr)
are all on the surface of the monomer, shown as spheres in Fig. 4A. In contrast, the
pentamer model only shows three of them on the surface of the pentamer. Asn210,
shown in cyan, is buried between the monomers, conforming well with the observed
non-glycosylated status for this Asn residue. The coloring of the potential glycosylation
sites in Figs. 4A–4D reflects their observed glycosylation status (presented below
under mass spectrometry).
Recombinant CA VI–PTX shows a high catalytic activity
Zebrafish CAVI–PTX was produced in insect cells with high yield. The purified
protein showed a single band close to the expected size in SDS-PAGE (Fig. 6, measured
MW 58.6 kDa, theoretical 58.107 kDa without glycans, signal peptide excluded).
Carbonate dehydratase activity was analyzed kinetically in the presence or absence of
acetazolamide. The kinetic parameters of CAVI–PTX (kcat and kcat/Km) were then
compared with those of the thoroughly investigated CAs, namely the cytosolic and
ubiquitous human isozymes a-CA I (hCA I) and II (hCA II). The CAVI–PTX possesses
considerable carbonate dehydratase activity as shown in Table 2. A kcat of 8.9  105 s-1
and a kcat/Km of 1.3  108 M-1  s-1 show that the enzymatic activity of CAVI–PTX
is almost in the same range with the very highly active human CA II. Data also show
that CAVI–PTX was efficiently inhibited, with an inhibition constant of 5 nM,
by the clinically-used sulfonamide, acetazolamide (5-acetamido-1,3,4-thiadiazole-2-
sulfonamide).
Light scattering analysis by LC–SLS–DLS confirms multimeric
structure
The molecular size of native recombinantly produced zebrafish CAVI–PTX was estimated
by SLS and DLS analysis after liquid chromatography. Gel filtration analysis indicated
main peak eluting at 1.52 ml retention volume according to A280 (Fig. 7, black curve).
This was associated with SLS intensity peak with identical shape. Analysis of the scattering
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intensity (SLS) results in a MW estimate of 280 ± 11 kDa for the peak, and the estimate
was homogeneous throughout the elution peak (Fig. 7, near-horizontal line across the
peak in dark gray). In addition, DLS data was collected for the eluted peak indicating
particle size of 7.69 ± 0.29 nm, as Rh (hydrodynamic radius), which is consistent with the
determined MW. The MW estimate based on the retention volume in gel filtration is
slightly smaller (214 ± 10 kDa), possibly due to off-globular shape of the molecule.
The small peak eluting before the main peak (∼1.1 ml retention volume) indicated the
presence of aggregated protein, resulting in high scattering intensity. According to A280,
this is less than 5% of the protein sample. Altogether, the light scattering analysis
combined with gel filtration indicates oligomeric assembly for the protein, a pentameric
form being the most probable oligomeric state.
Figure 6 SDS-PAGE of recombinantly produced zebrafish CA VI–PTX. Left: purified recombinant
zebrafish CA VI–PTX, molecular mass calculated from mobility 58.6 kDa. Right: molecular weight
standards. Full-size DOI: 10.7717/peerj.4128/fig-6
Table 2 Kinetic parameters for CO2 hydration reaction catalyzed by selected a-CA isozymes.
Enzyme kcat (s
-1) Km (mM) kcat/Km (M
-1 s-1) KI(AAZ) (nM)
hCA Ia 2.0  105 4.0 5.0  107 250
hCA IIa 1.4  106 9.3 1.5  108 12
Pentraxin-CA VIb 8.9  105 6.5 1.3  108 5
Notes:
AAZ, acetazolamide, 5-acetamido-1,3,4-thiadiazole-2-sulfonamide.
a Human recombinant isozymes, stopped flow CO2 hydratase assay method (pH 7.5) (Nishimori et al., 2007).
b Zebrafish recombinant enzyme, stopped flow CO2 hydratase assay method (pH 7.5), this work.
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Mass spectrometry confirms post-translational modifications
All attempts to characterize the intact CAVI–PTX with ESI FT-ICR mass spectrometry
failed, despite the extensive sample desalting/purification prior to the measurements.
This may be due to a slight protein precipitation observed during the sample preparation.
Therefore, in-solution trypsin digestion was selected as the main route for structural
characterization of CAVI–PTX. The digestion was performed in non-reducing conditions
to preserve disulfide bonds in the structure. The digestion resulted in 97% sequence
coverage with 64 specific tryptic peptides identified (Figs. 8 and 9, and fuller details in
Fig. S6 and Table S1).
The peptide map in Fig. 9 shows that the tryptic peptides were found within both
protein domains, although somewhat larger peptides (up to ∼14 kDa) were found within
the PTX domain. Out of all identified peptides, 12 contained disulfide bonds (either intra-
or interpeptide). These peptides confirmed the putative disulfide bonds, Cys 44/226 in the
CA domain, and Cys 352/408 and Cys 487/518 in the PTX domain. Cys290 in the spacer
region is most likely free but the corresponding tryptic peptide (LSKGGMCR) was not
observed to confirm this. These disulfide bonds are fully consistent with the 3D structural
model of CAVI–PTX.
Carbonic anhydrase VI–pentraxin contains four putative N-glycosylation sites
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Figure 7 Assessment of the oligomeric size of zebrafish CAVI. Gel permeation chromatography was
used to study the characteristics of recombinantly produced zebrafish CAVI. The left Y-axis shows the
UV absorption intensity (280 nm wavelength) and light scattering (LS) intensity. UV intensity was used
for the determination of the protein concentration. Molecular weight (MW) was calculated using LS
intensity and shown on the right Y-axis. Hydrodynamic radius (Rh) was calculated from the dynamic
light scattering signal, and is also shown on the right Y-axis. In addition, the oligomeric size of zebrafish
CA VI was evaluated based on the penetration time using molecular weight marker proteins as a
standard. Full-size DOI: 10.7717/peerj.4128/fig-7
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(marked in Fig. 9). Among the identified tryptic peptides, 12 glycopeptides were found.
On the basis of these peptides, CAVI–PTX carries two glycans, a core-fucosylated
oligomannose type glycan GlcNAc2(Fuc)Man3 at Asn258 and an oligomannose type
glycan GlcNAc2Man3 at Asn339, located in the CA domain and PTX domain, respectively.
These glycosylation sites and glycan structures were further verified by CID-MS/MS
experiments of the representing glycopeptides [248–266] (3416.5084 Da) and [331–347]
(2819.3059 Da) (Fig. 10). As no other glycan variants were observed among the peptides,
it seems that the glycosylation in CAVI–PTX (produced in insect cells) is rather
homogenous. These results are consistent with accessibility of the sites predicted by our
model. Interestingly, the glycosylation site at Asn258 is conserved in 77 out of 78 non-
mammalian CAVI sequences in the sequence alignment Fig. S1 (columns 266–268). The
tryptic peptide [191–216] (2988.4744 Da) was only observed in a free form, indicating
that Asn210 is non-glycosylated in the CA domain. Similarly, the peptides spanning
the Asn394 residue were all observed without any glycans attached (Fig. S6), suggesting
that this site is non-glycosylated in the PTX domain.
Immunohistochemistry shows cell surface localization of
CA VI–PTX in various tissues
Recombinant zebrafish CAVI–PTX protein was used to raise a rabbit polyclonal
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Figure 8 High-resolution mass spectrum of the tryptic digest of CAVI-PTX. The mass spectrum was
measured by direct infusion on a 12-T Fourier transform ion cyclotron resonance instrument using
positive-ion electrospray ionization. Monoisotopic m/z values and charge states obtained through peak
deconvolution are indicated for the most abundant peaks. Full-size DOI: 10.7717/peerj.4128/fig-8
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staining in the skin, heart, gills, and swim bladder. The strongest signal is seen on cell
surfaces, while the intracellular staining was detectable but weaker.
To get further insights into ca6 expression in zebrafish, we also studied the expression
pattern in different tissues of adult zebrafish by qRT-PCR. As shown in Table 3,
relative expression of ca6 mRNA was found to be prominent in the fins/tail, and brain.
Low levels of expression were observed in the gills, kidney, teeth, skin, and spleen. A very
faint signal was detected in the swim bladder, intestine, pancreas, liver, eggs, and heart.
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Figure 9 A tryptic peptide map of selected peptides of zebrafish CAVI–PTX. The identified tryptic
peptides are indicated with blue boxes showing the start and the end residues. The confirmed disulfide
bonds are indicated with red lines with the corresponding peptides indicated with red boxes. The four
potential N-glycosylation sites are indicated with a distinct background color (blue: unoccupied
N-glycosylation site; and green: occupied N-glycosylation site). The three observed glycopeptides are
marked with purple boxes. The start of the PTX domain (KQP : : : ) has been indicated with a black
arrow. This figure shows a minimum amount of peptides for maximal coverage, whereas all identified
peptides are shown in Fig. S6. Full-size DOI: 10.7717/peerj.4128/fig-9
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Figure 10 Characterization of zebrafish CA VI–PTX glycopeptides by tandem mass spectrometry.
The precursor ions of the two observed glycopeptides, with monoisotopic masses of 3416.5084 Da
and 2819.3059 Da (residues 248–266 and 331–347, respectively), were mass-selected in a quadrupole for
collision-induced dissociation tandem mass spectrometry. The fragmentation patterns are consistent
with the presence of the standard N-glycosylation core pentasaccharide with fucosylation in the
innermost N-acetylglucosamine residue in the glycopeptide 248–266 (A) and a similar non-fucosylated
pentasaccharide in the glycopeptide 331–347 (B). Full-size DOI: 10.7717/peerj.4128/fig-10
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Zebrafish cannot swim properly in the ca6 knockdown model
Gene-specific antisense MOs have been widely used to inhibit gene expression in zebrafish
larvae (Eisen & Smith, 2008). We designed two different MOs, one for translational
blocking of ca6mRNA and the other for blocking intron splicing before exon 9. BothMOs
were used to repeat all knockdown experiments with highly similar results, suggesting
equally efficient knockdown in both kinds of ca6 morphants. We did not see any
morphological differences between uninjected and RC MO-injected embryos/larvae over
the period of five days of development. The ca6 morphant zebrafish embryos between
1 and 3 dpf were also devoid of any notable morphological changes, but interestingly,
at the end of 4 dpf we consistently observed an underdeveloped or deflated swim bladder
in ca6 morphant larvae (Fig. 12).
Figure 11 Immunohistochemistry of CAVI–PTX in adult zebrafish tissues. Tissue sections stained by
anti-zebrafish CA VI–PTX (green) and nuclear staining by DAPI (blue). Gills (A), heart (B), skin (C),
swim bladder (D). The strongest signal (A–D) is present on the cell surfaces, even though the cell interior
gives some background staining. Scale bars 100 mm. Full-size DOI: 10.7717/peerj.4128/fig-11
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The quantitative expression analysis of ca6 mRNA was done in wild-type and the ca6
morphant zebrafish at different stages of development. As seen in Fig. 13, the mRNA
expression in wild-type embryos was highest at 24 hpf, with slightly lower values later.
The levels of ca6 mRNA were consistently higher in the morphant embryos compared
to the wild-type, possibly because of compensatory upregulation of the gene caused by
the absence of CAVI protein. The peak expression of ca6 was at 48 hpf in the ca6
morphant embryos.
In order to measure swimming activity of morphant vs. wild-type, we calculated total
distances traveled for individual larvae, and they are presented as boxplots in Fig. 3.















Figure 12 Comparison between morpholino-injected and wild-type zebrafish larvae. The morphant
larvae (A) showed consistently a deflated swim bladder at 4 dpf (arrow), which returned to normal
morphology at 5 dpf. Wild-type larvae of the same ages are shown for comparison (B). Scale bars 1 mm.
Full-size DOI: 10.7717/peerj.4128/fig-12























































Figure 13 Developmental expression pattern of ca6 in 1–5 dpf larvae. The expression levels of the ca6
gene was studied using qRT-PCR from the total mRNA isolated from 1 to 5 dpf of ca6 morphant and
wild-type larvae. The results of ca6 gene expression were normalized using gapdh as internal control.
Full-size DOI: 10.7717/peerj.4128/fig-13
Table 4 Statistics of swimming pattern analysis of ca6 morphant and wild-type zebrafish.
Aa Median Mean SD Range p-Value
Day 4
KD 0.00 1.87 6.59 0.00–49.03 4.28  10-19 b
WT 13.80 13.12 6.01 0.00–25.45 1.90  10-3 c
Day 5
KD 4.75 4.89 4.26 0.00–5.19 1.16  10-7 b
WT 10.22 10.38 3.18 1.83–17.27
Bd Median Mean SD Range p-Value
Day 4
KD 0 9.13 20.46 0.00–60.00 8.68  10-11 b
WT 31 29.59 22.44 0.00–60.00 4.98  10-3 c
Day 5
KD 24.51 26.96 26.23 0.00–60.00 2.98  10-4 b
WT 51.47 45.29 16.42 0.00–60.00
Notes:
KD, knockdown; WT, wild-type.
a Swimming distances (cm).
b KD compared to WT.
c Day 4 WT compared to day 5 WT.
d Time spent in upper half of the flask.
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Two-sample Kolmogorov–Smirnov statistical analyses were performed between relevant
group pairs to determine if they could have been drawn from the same distribution.
Day 4 knockdown larvae swam less (median 0.00 cm) than day 4 wild-type larvae (median
13.80 cm, p-value 4.28 10-19), and similarly day 5 knockdown larvae swam less (median
4.75 cm) than day 5 wild-type larvae (median 10.22 cm, p-value 1.16  107). Full details
of the swimming data are shown in Table 4. Taken together with the clearly observed
swim bladder deficiency in 4 dpf larvae (Fig. 12) and the presence of CAVI in adult
zebrafish swim bladder, we suggest that CAVI is required either for swim bladder
development or swim bladder function. When CAVI expression is mainly restored in
5 dpf larvae, the swimming pattern also returns to almost normal.
DISCUSSION
This study consists of the characterization of a novel type of a CA, CAVI containing a PTX
domain, by means of sequence analyses, phylogenetics, molecular modeling, experiments
on a recombinantly produced protein, knockdown of the ca6 gene in zebrafish embryos,
and expression studies by immunohistochemistry and qRT-PCR. The bioinformatic
and experimental analyses build a coherent picture of the structure of this novel domain
combination, and the evolutionary analysis shows a history of domain gains and losses.
Based on our previous work and the findings in this study, we propose that CAVI–PTX
in zebrafish is needed for filling the swim bladder, and possibly in a novel type of
membrane anchoring and immune function.
The PTX domain found associated with non-mammalian CAVI is a novel member
of the PTX family. We have shown it to be most closely related with the short PTXs,
CRP and SAP (Fig. 2). The association of a CA domain with a PTX domain is new in both
the PTX and CA families. SAP and CRP are more closely similar to each other than either
is to the CA-associated PTX domain. This could indicate that the CA-associated PTX
domain had diverged from a common ancestor before the duplication that created
SAP and CRP, but we cannot take this for granted, because adaptation to create a
viable domain interface may have accelerated the rate of change in the CA-associated
PTX domain.
The phylogenetic tree in Fig. 1 shows that the TM CAs IX, XII, and XIV and secretory
CA VI share a common ancestor. We propose that the quartet has arisen in the two
whole-genome duplications in early vertebrates. Figure 14 presents a plausible sequence of
events that could have led to present-day domain structures in CAVI. Briefly, we
assume that the exon coding for the cytoplasmic domain in ancestral CAVI was replaced
by an exon coding for a PTX domain (probably by a duplication or a move of an exon
coding for a short PTX in early vertebrates), and the TM helix transformed into an APH
(Figs. 4 and 5). Later, presumably in the therian mammal lineage, the PTX domain was
lost, leaving the APH in the C-terminus of CAVI. These hypotheses are supported by the
following observations: (1) Comparison of exon lengths suggests the TM-helix-coding
exon as the most likely ancestor of the exon coding the spacer region after the CA domain
in CAVI; (2) the losses of the CP domain in early CA VI and of PTX domain in
mammalian lineage are more parsimonious assumptions than their acquisition in
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multiple lineages; (3) the duplication of the glucose transporter genes SLC2A5 and
SLC2A7, as seen in therian mammals, is evidence of rearrangements in the region adjacent
to the PTX-domain-coding exon of the CA6 locus, which we assume to have led to the
loss of the PTX domain in mammalian CAVI; and (4) the PTX domain is consistently
present in non-mammalian CAVI and missing from mammalian CAVI (most likely
excepting platypus).
Considering the monomer MW of 58.1 kDa (plus glycosylation), the LC–SLS–DLS
results clearly confirm that zebrafish CAVI is an oligomer. The MWestimated by LC–SLS
(280 ± 11 kDa) is slightly less than MW calculated from sequence (290.5 kDa for
pentamer, plus glycosylation). Based on the gel filtration retention volume and protein
standards, the MW is estimated to be slightly smaller (214 ± 10 kDa), but this result may
be affected by column interactions and deviation from the globular shape. Furthermore,
the hydrodynamic radius calculated from light scattering (7.69 ± 0.29 nm; diameter
15.38 ± 0.58 nm) suggests a particle size in the range of 364–434 kDa for globular particle.
In this context, it has to be noted that diffusion of the particle is highly dependent on the
molecular shape and DLS-based estimate may also be slightly affected by irregular shape.
Figure 14 Hypothesis of evolution of the domain composition in CAVI and the transmembrane CA
isoforms. CA, catalytic CA domain; TMH, transmembrane helix; APH, amphipathic helix; PTX,
pentraxin domain; PG, proteoglycan domain. Image credit: Original digital art by Jukka Lehtiniemi.
Full-size DOI: 10.7717/peerj.4128/fig-14
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Taken together, the light scattering results are more compatible with a pentamer than
tetramer or hexamer models. The 3D model of CAVI–PTX as a pentamer (Figs. 5B–5D)
predicts a shape of a flat, roughly planar five-pointed star, thickness 4–5 nm and
approximate diameter 15 nm, i.e., clearly off-globular, which would explain the
minor conflicts between observations. What is more, the pentamer model is also
supported by known pentamerization of related PTXs (CRP and SAP). However, we
need to stress that the relative orientations of the CA and PTX domains in our models
are only tentative.
Mass spectrometry confirms that the N-terminus of the mature CAVI–PTX
coincides with the predicted signal peptide cleavage site between residues 19 and 20.
Glycopeptides with typical N-linked glycans are observed associated with Asn258
and Asn339, whereas the peptides containing Asn210 or Asn394 are only seen in
non-glycosylated form (Fig. 9). Consistent with these observations of N-glycosylation,
our 3D model of pentameric CAVI–PTX (Figs. 5B–5D) shows that Asn258 and Asn339
are well exposed, whereas Asn210 is fully buried in the protomer/domain interface,
and Asn394 would be somewhat hindered at the protomer interface.
We discovered a minor but surprising outcome in the knockdown model regarding the
poor floating ability, most likely caused by a deflated swim bladder, both of which we
observed consistently in 4 dpf knockdown larvae. The statistically significant lower
swimming distances and stationary positioning at the bottom of 4 dpf knockdown
larvae, vs. those of 4 dpf wild-type larvae or 5 dpf knockdown larvae, imply that the
knockdown larvae gain normal swimming function as the knockdown action of the
injected MOs is relieved (Fig. 12). CA VI–PTX function within the swim bladder is
further supported by immunohistochemistry and qRT-PCR, showing expression of
both CAVI–PTX protein and mRNA in the swim bladder specimens. However, at the
current point we cannot distinguish whether the swim bladder dysfunction observed
in 4 dpf larvae is due to delayed development or the need of CAVI–PTX in swim
bladder inflation.
C-reactive protein and serum amyloid P are known to bind carbohydrates, i.e., they are
lectins (Hind et al., 1984; Kottgen et al., 1992). The calcium-binding residues in the
sugar binding site are partially conserved between these two lectins and the CA-associated
PTX domain. In addition, PTXs are a subfamily of the Concanavalin A-like lectin/
glucanase family, which contains numerous other lectins (leguminous plant lectins,
animal galectins, etc.) and other proteins interacting with carbohydrates (http://www.ebi.
ac.uk/interpro/entry/IPR013320). In our immunohistochemistry results the CAVI–PTX
protein shows mostly a strong cell-surface staining pattern (Fig. 11), even if the protein is
predicted to be a secreted, soluble protein. We assume that the PTX domain in CAVI
would also be a lectin and anchor the protein on the cell surface via sugars in
glycoconjugates. Binding to plasma membrane glycoconjugates would also explain
why the loss of the TMH was tolerated, i.e., TM helix anchoring was replaced by
lectin anchoring. If sugar binding by CAVI–PTX can be proved experimentally,
non-mammalian CAVI would represent the first case of an enzyme which is attached
on the cell surface by lectin binding.
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Lectins and other PRMs are an important part of the innate immune system in fishes,
which is more diverse than that of mammals (Vasta et al., 2011; Sunyer, Zarkadis &
Lambris, 1998). Although teleost fish lack lymph nodes and bone marrow, the anterior
part of the fish kidney is considered a functional ortholog of mammalian bone marrow.
Thus, it represents the main hematopoietic lymphoid tissue of teleosts, and is thought to
be an immunologically responsive organ (Zapata & Amemiya, 2000). The role of
maintenance of mucosal homeostasis is served in teleosts by the gut, skin, and gills, which
all contain mucosa-associated lymphoid tissue (Salinas, Zhang & Sunyer, 2011). These
are among the tissues where zebrafish CAVI–PTX has its highest expression, and therefore
we assume that this protein is a part of the innate immune system.
Interestingly, we have shown that mouse CAVI is also highly expressed in the gut,
specifically in the immunologically active Peyer’s patches (Pan et al., 2011). In another
study, we demonstrated that there is a likely role for Car6 in immune stimulated lung
tissues (Patrikainen et al., 2016) and murine Car6 is likely involved in mucosa
maintenance in both airways and gut (Leinonen et al., 2004; Parkkila et al., 1997).
We formed a preliminary hypothesis that mouse CAVI is involved in immunological
functions, which has been confirmed recently (Xu et al., 2017), by showing that CAVI
isoform B promotes interleukin-12 expression. However, a gene regulatory function is
unlikely for zebrafish CAVI, with the estimated diameter of 15 nm for the pentamer
making it too large to enter the nuclear pores. The locations of high ca6/CA6 expression in
fish and in mammals are similar in that they allow delivery of CA VI on the physical
barrier against external environment (gut, skin, and gills in zebrafish; skin, saliva, milk,
and lungs in human/mouse), consistent with a function associated with primary immune
defense. Summing up, we suggest that both mammalian and fish CAVI are components of
the innate immune system, with or without a PTX domain.
Given the dynamic nature of genomes, with transposition and translocation events
constantly shuffling exons, it is hard to see the choreography of domain moves in CAVI
during vertebrate evolution as anything more than chance events. However, in order to
remain stably in a genome, the changes must be at least tolerated, or possibly provide
some advantage to their carrier. We see the addition of the PTX domain in early jawed
vertebrates as a tolerated change, in which membrane attachment through a TM helix was
replaced by lectin anchoring. As we have suggested, the new domain context may have led
to the CA domain of CAVI adopting functionality within the innate immune system.
Then later, when the PTX domain was lost, presumably through the local segmental
duplication leading to a duo of glucose transporters (SLC2A5 and SLC2A7), the addition
of another glucose transporter may have been more of an advantage than the loss of
pentamerization and membrane anchoring in CAVI, and thus this chromosomal
arrangement became fixed in early therian mammals. The loss of the PTX domain may
also have opened the way for using the APH in forming dimers. We have a preliminary
result of human CAVI being a mixture of monomer and dimer forms in solution
(A. Yrja¨na¨inen, 2017, unpublished data), in which we speculate dimerization to be
mediated by the amphipathic helices being able to join in a coiled-coil fashion when
unhindered by a further C-terminal domain.
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This study has given us many ideas for future research. We plan to take a closer look at
the complex evolution of non-mammalian PTXs, which might shed more light on the
origin of the CAVI-linked PTX domain and on structure-related constraints on its
surface. We have also started work on comparisons of per-residue conservation patterns of
the CA domain in mammalian vs. non-mammalian CAVI. Testing the sugar-binding
ability of CAVI–PTX will be the obvious way to explore the lectin hypothesis.
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